Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Vigil Neuroscience, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +1 vs. Q3 2024
- Shares held
- 22.6M
- −855.5K (−3.6%) vs. Q3 2024
- Total value
- $38.4M
- −$41.3M (−51.8%) vs. Q3 2024
- New holders
- 12
- 19 more added
- Sold out
- 11
- 11 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $9.92M | 1.21% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,991,038 | $3.38M | 0.15% | 00.0% | Unchanged |
| BVF Inc | 1,813,633 | $3.08M | 0.10% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,507,192 | $2.56M | 0.00% | +64,724+4.5% | Added |
| Sphera Funds Management Ltd. | 1,502,429 | $2.55M | 0.47% | −145,175−8.8% | Reduced |
| 683 Capital Management, LLC | 1,400,000 | $2.38M | 0.23% | +180,420+14.8% | Added |
| Vanguard Group Inc | 975,473 | $1.66M | 0.00% | +70,742+7.8% | Added |
| Ensign Peak Advisors, Inc | 703,116 | $1.20M | 0.00% | +97,580+16.1% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $953.0K | 0.64% | 00.0% | Unchanged |
| Standard Life Aberdeen plc | 528,472 | $898.4K | 0.00% | +293,461+124.9% | Added |
| Ikarian Capital, LLC | 500,000 | $850.0K | 0.24% | +500,000 | New |
| Woodline Partners LP | 488,756 | $830.9K | 0.01% | +344,614+239.1% | Added |
| Rock Springs Capital Management LP | 471,958 | $802.3K | 0.03% | 00.0% | Unchanged |
| BlackRock, Inc. | 420,702 | $715.2K | 0.00% | −1,845−0.4% | Reduced |
| Renaissance Technologies LLC | 367,300 | $624.4K | 0.00% | +321,300+698.5% | Added |
| Millennium Management LLC | 343,814 | $584.5K | 0.00% | +65,058+23.3% | Added |
| Blair William & Co | 323,900 | $550.6K | 0.00% | +323,900 | New |
| ArrowMark Colorado Holdings LLC | 289,460 | $492.1K | 0.01% | 00.0% | Unchanged |
| Marshall Wace, LLP | 266,895 | $453.7K | 0.00% | +122,853+85.3% | Added |
| Goldman Sachs Group Inc | 256,642 | $436.3K | 0.00% | +256,642 | New |
| Point72 Asset Management, L.P. | 250,000 | $425.0K | 0.00% | −1,350,000−84.4% | Reduced |
| Geode Capital Management, LLC | 228,524 | $388.6K | 0.00% | +2,441+1.1% | Added |
| Susquehanna International Group, LLP | 212,664 | $361.5K | 0.00% | +212,664 | New |
| Trustees of Columbia University in the City of New York | 192,973 | $328.1K | 0.05% | +192,973 | New |
| Boothbay Fund Management, LLC | 146,750 | $249.5K | 0.01% | +146,750 | New |
| Two Sigma Investments, LP | 136,920 | $232.8K | 0.00% | +41,836+44.0% | Added |
| Squarepoint Ops LLC | 113,596 | $193.1K | 0.00% | +113,596 | New |
| Qube Research & Technologies Ltd | 108,482 | $184.4K | 0.00% | +65,897+154.7% | Added |
| Verition Fund Management LLC | 107,536 | $182.8K | 0.00% | −22,494−17.3% | Reduced |
| Bridgeway Capital Management, LLC | 100,064 | $170.1K | 0.00% | −5,000−4.8% | Reduced |
| State Street Corp | 69,139 | $117.5K | 0.00% | +28,400+69.7% | Added |
| Two Sigma Advisers, LP | 69,100 | $117.5K | 0.00% | +49,000+243.8% | Added |
| Northern Trust Corp | 64,737 | $110.1K | 0.00% | +14,572+29.0% | Added |
| Barclays PLC | 64,049 | $108.9K | 0.00% | +19,436+43.6% | Added |
| Jane Street Group, LLC | 48,812 | $83.0K | 0.00% | +48,812 | New |
| Acadian Asset Management LLC | 37,905 | $63.0K | 0.00% | +37,905 | New |
| Cubist Systematic Strategies, LLC | 24,120 | $41.0K | 0.00% | +8,358+53.0% | Added |
| American Century Companies Inc | 19,970 | $33.9K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 18,130 | $30.8K | 0.00% | −30,253−62.5% | Reduced |
| ADAR1 Capital Management, LLC | 15,543 | $26.4K | 0.01% | −6,194−28.5% | Reduced |
| Engineers Gate Manager LP | 13,695 | $23.3K | 0.00% | +13,695 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 10,836 | $18.4K | 0.00% | −851−7.3% | Reduced |
| Tower Research Capital LLC (TRC) | 8,934 | $15.2K | 0.00% | +5,422+154.4% | Added |
| Bank of America Corp | 1,097 | $1.86K | 0.00% | −22,366−95.3% | Reduced |
| R Squared Ltd | 910 | $1.55K | 0.00% | +910 | New |
| JPMorgan Chase & Co | 382 | $649 | 0.00% | −32−7.7% | Reduced |
| Federated Hermes, Inc. | 313 | $532 | 0.00% | +115+58.1% | Added |
| BNP Paribas Arbitrage, SA | 228 | $388 | 0.00% | +228 | New |
| Morgan Stanley | 11 | $19 | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 7 | $12 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $2 | 0.00% | −282−99.6% | Reduced |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −1,553,996−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −743,719−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −448,891−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −119,792−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −26,329−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −4,100−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −2,086−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −471−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −5,933−100.0% | Sold out |
| Northpond Ventures, LLC | – | – | – | – | Not filed |
| PEAK6 Investments LLC | – | – | – | – | Not filed |